SEC Form 4 · accession 0001209191-19-018252
ARENA PHARMACEUTICALS INC · ARNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tina Susan Nova
Director
Period of report
Mar 7, 2019
Accepted (ET)
Mar 8, 2019 · 6:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001080709
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 7, 2019 | M | 1,200 | $40.10 | A | 12,676 | D | |
| Common Stock | Mar 7, 2019 | S | 1,200 | $45.9855 | D | 11,476 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $40.10 | Mar 7, 2019 | M | 1,200 | D | — | Mar 17, 2019 | Common Stock | 1,200 | 0 | D |
Explanation of responses
- F1The options vested in twelve equal monthly installments beginning on April 17, 2009, and were immediately exercisable once vested.